Skip to main content
Mithra Pharmaceuticals S.A. logo

Mithra Pharmaceuticals S.A. — Investor Relations & Filings

Ticker · MITRA ISIN · BE0974283153 LEI · 5493002FDD273HTEKK14 BR Manufacturing
Open in API
Filings indexed 754 across all filing types
Latest filing 2024-01-25 Share Issue/Capital Cha…
Country BE Belgium
Listing BR MITRA

About Mithra Pharmaceuticals S.A.

https://www.mithra.com/

Mithra Pharmaceuticals S.A. is a biotech company dedicated to women's health. The company focuses on the development, manufacturing, and commercialization of differentiated drugs and complex therapeutic solutions. Its core areas of expertise include contraception, fertility, and menopause. Mithra aims to transform the women's health sector by providing innovative choices to support and improve the overall quality of life for women.

Recent filings

Filing Released Lang Actions
2024-01-25_Mithra_Press-release_Notice-of-Adjustment_EN.pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025". It explicitly discusses changes to the terms of financial instruments (convertible bonds), specifically adjusting the conversion price due to a prior share issuance. This relates directly to the company's capital structure and financing terms. While it is a regulatory notice ('NOTICE REGULATED INFORMATION'), the specific subject matter—adjustment of convertible bond terms—fits best under 'Capital/Financing Update' (CAP) rather than the general 'Regulatory Filings' (RNS) or 'Interest Rate Update' (IRAT). The document is short and appears to be an announcement of a specific financial event, not a comprehensive report.
2024-01-25 English
2024-01-25_Mithra_Press-release_Notification-adjustement_FR.pdf
Capital/Financing Update Classification · 98% confidence The document is dated 25-01-2024 and is titled "Notification d'ajustement du prix de conversion des obligations convertibles seniors non garanties..." (Notification of adjustment to the conversion price of senior unsecured convertible bonds...). This announcement details a specific change to the terms of existing financial instruments (convertible bonds) due to a prior issuance of warrants/rights. This action directly relates to the company's capital structure and financing terms. Among the provided codes, 'Capital/Financing Update' (CAP) is the most appropriate fit for an announcement detailing an adjustment to the conversion price of outstanding debt instruments based on previous financing activities. It is not a general earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it concerns a specific financial mechanism adjustment.
2024-01-25 French
2023-12-22_Mithra_Press-release_Transparency-notification-GS_EN.pdf
Major Shareholding Notification Classification · 98% confidence The document explicitly states it is a 'Publication of a transparency notification received from The Goldman Sachs Group Inc.' and details a change in major shareholding percentage (dropping below the 3% threshold) in accordance with the Belgian Transparency Law. This directly relates to changes in significant ownership levels, matching the definition for Major Shareholding Notification (MRQ). Although it is a notification about a filing, the content itself is the core information regarding the shareholding change, making MRQ more specific than a general RPA or RNS.
2023-12-22 English
2023-12-22_Mithra_Press-release_Transparency-notification-GS_FR.pdf
Major Shareholding Notification Classification · 98% confidence The document is a press release titled "Publication d'une notification de transparence reçue de la part de Goldman Sachs Group Inc." (Publication of a transparency notification received from Goldman Sachs Group Inc.). It explicitly states that Mithra received a transparency notification from Goldman Sachs Group Inc. regarding a change in shareholding percentage, falling below the 3% threshold as per Belgian transparency regulations. This type of filing, which reports changes in significant share ownership by an investor, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a press release announcing the event, the core subject matter is the change in major shareholding, making MRQ the most specific classification over a general RPA or RNS.
2023-12-22 French
2023-12-20_Mithra_Press-release_ESTELLE-pediatric-closes_EN.pdf
Regulatory Filings Classification · 95% confidence The document is a press release issued by Mithra Pharmaceuticals announcing the completion of a pediatric clinical study for their product ESTELLE. It provides details on the study's scope, the regulatory context (EMA/PIP), and the expected timeline for data release. It does not fit into specific financial reporting categories like 10-K or IR, nor is it a report publication announcement (RPA) as it is the primary announcement of the clinical milestone itself. As it is a general corporate announcement regarding business operations and clinical progress, it falls under the Regulatory Filings (RNS) category.
2023-12-21 English
2023-12-20_Mithra_Press-release_ESTELLE-pediatric-closes_FR.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Mithra Pharmaceuticals announcing the completion of a pediatric clinical study for their product ESTELLE. It provides details on the study's purpose, the regulatory context (EMA/PIP), and the expected timeline for results. It does not contain full financial statements, audit reports, or proxy materials. As it is a corporate announcement regarding operational/clinical progress, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2023-12-21 French

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.